Toru Hiraiwa

Title: Toru Hiraiwa: Innovator in Cerebrovascular Disease Treatment

Introduction

Toru Hiraiwa is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cerebrovascular diseases. With a total of 5 patents to his name, Hiraiwa's work is recognized for its potential impact on medical science.

Latest Patents

Hiraiwa's latest patents include innovative compounds such as a 1,2-benzoisoxazole derivative or its salt, which showcases his focus on developing effective treatments. Another significant patent is for a brain-protecting agent, specifically a piperazine derivative or its salt, along with the process for producing the same. Additionally, he has developed a piperazine derivative represented by a specific formula, which is useful for curing cerebrovascular disease and post-cerebrovascular disease.

Career Highlights

Hiraiwa is currently associated with Toyama Chemical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from cerebrovascular conditions.

Collaborations

Hiraiwa collaborates with esteemed colleagues such as Joji Nakano and Isao Watanabe, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Toru Hiraiwa's contributions to the field of pharmaceuticals, particularly in cerebrovascular disease treatment, highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to improving medical outcomes for patients.